Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis-Reference-Cited by-同舟云学术

Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis

Published:2021-01-01 Issue:1 Volume:59 Page:1594-1606
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Zhou Yuan¹^ORCID,Wu Rong¹,Cai Fei-fei¹,Zhou Wen-Jun¹,Lu Yi-Yu¹,Zhang Hui¹,Chen Qi-Long¹,Sun Ming-Yu²,Su Shi-Bing¹^ORCID

Affiliation:

1. Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China

2. Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Funder

Major Project of Shanghai Municipal S&T Commission

National Science Foundation of China

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2021.1999275

Reference50 articles.

1. Aloe–emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells

2. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis